Turnstone Biologics (TSBX) Institutional Ownership → “Dollar Will Be Worth NOTHING” -Musk (From Crypto 101 Media) (Ad) Free TSBX Stock Alerts $2.68 -0.05 (-1.83%) (As of 01:17 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Turnstone Biologics (NASDAQ:TSBX)CurrentInstitutional OwnershipPercentage52.51%Number ofInstitutional Buyers(last 12 months)7TotalInstitutional Inflows(last 12 months)$16.54MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$2.35M Get TSBX Insider Trade Alerts Want to know when executives and insiders are buying or selling Turnstone Biologics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TSBX Institutional Buying and Selling by Quarter Ad Crypto 101 Media“Dollar Will Be Worth NOTHING” -MuskElon Musk just issued an urgent warning… Saying “The U.S. Dollar will be worth NOTHING…” As "stealth money printing" pushes the price of Bitcoin, Ethereum, XRP and crypto higher.Click here to claim your free seat ticket now. Turnstone Biologics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/17/2024 Zimmer Partners LP179,026$469K0.0%+271.4%0.774% 4/17/2024 Kathleen S. Wright Associates Inc.42,553$111K0.1%N/A0.184% 2/15/2024 PFM Health Sciences LP633,313$1.61M0.1%-58.5%2.742% 2/15/2024 Caas Capital Management LP45,831$117K0.0%-40.1%0.198% 12/6/2023 Citigroup Inc.7,524$30K0.0%N/A0.033% 11/15/2023 Sectoral Asset Management Inc.517,648$2.04M0.4%N/A2.266% 11/14/2023 Eventide Asset Management LLC708,317$2.79M0.1%N/A3.101% 11/13/2023 FMR LLC2,830,284$11.15M0.0%N/A12.392% 11/7/2023 New York State Common Retirement Fund18,867$74K0.0%N/A0.083% (Data available from 1/1/2016 forward) TSBX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TSBX shares? During the previous two years, 9 institutional investors and hedge funds held shares of Turnstone Biologics. The most heavily invested institutionals were FMR LLC ($11.15M), Eventide Asset Management LLC ($2.79M), Sectoral Asset Management Inc. ($2.04M), PFM Health Sciences LP ($1.61M), Zimmer Partners LP ($469K), Caas Capital Management LP ($117K), and Kathleen S. Wright Associates Inc. ($111K).Learn more on TSBX's institutional investors. What percentage of Turnstone Biologics stock is owned by institutional investors? 52.51% of Turnstone Biologics stock is owned by institutional investors. Learn more on TSBX's institutional investor holdings. Which institutional investors have been buying Turnstone Biologics stock? The following institutional investors have purchased Turnstone Biologics stock in the last 24 months: FMR LLC ($2.83M), Eventide Asset Management LLC ($708.32K), Sectoral Asset Management Inc. ($517.65K), Zimmer Partners LP ($130.83K), Kathleen S. Wright Associates Inc. ($42.55K), New York State Common Retirement Fund ($18.87K), and Citigroup Inc. ($7.52K). How much institutional buying is happening at Turnstone Biologics? Institutional investors have bought a total of 4,256,019 shares in the last 24 months. This purchase volume represents approximately $16.54M in transactions. Which Turnstone Biologics major shareholders have been selling company stock? The following institutional investors have sold Turnstone Biologics stock in the last 24 months: PFM Health Sciences LP ($891.40K), and Caas Capital Management LP ($30.68K). How much institutional selling is happening at Turnstone Biologics? Institutional investors have sold a total of 922,074 shares in the last 24 months. This volume of shares sold represents approximately $2.35M in transactions. Related Companies: Atara Biotherapeutics Institutional Ownership Ikena Oncology Institutional Ownership Elutia Institutional Ownership Instil Bio Institutional Ownership Genenta Science Institutional Ownership Aligos Therapeutics Institutional Ownership Cidara Therapeutics Institutional Ownership Precision BioSciences Institutional Ownership Cognition Therapeutics Institutional Ownership LENZ Therapeutics Institutional Ownership This page (NASDAQ:TSBX) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldI’m afraid WWIII is a very real possibility Porter & CompanyMissed NVDA? Buy this AI stock NOWChaikin AnalyticsDems have chosen Biden replacement?Paradigm PressDoes this make you sick?Allegiance GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportWhy Is Gold On a MASSIVE rally? Huge Alerts348 million Americans lives to END as we know it?The Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Turnstone Biologics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
